Works by Kazakin, J

A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours.

Published in:

2017

By:

• Papadopoulos, K P;
• El-Rayes, B F;
• Tolcher, A W;
• Patnaik, A;
• Rasco, D W;
• Harvey, R D;
• LoRusso, P M;
• Sachdev, J C;
• Abbadessa, G;
• Savage, R E;
• Hall, T;
• Schwartz, B;
• Wang, Y;
• Kazakin, J;
• Shaib, W L

Publication type:

journal article